mTOR Blockade by Rapamycin in Spondyloarthritis: Impact on Inflammation and New Bone Formation in vitro and in vivo-Reference-Cited by-同舟云学术

mTOR Blockade by Rapamycin in Spondyloarthritis: Impact on Inflammation and New Bone Formation in vitro and in vivo

Published:2020-02-27 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Chen Sijia,van Tok Melissa N.,Knaup Véronique L.,Kraal Lianne,Pots Désiree,Bartels Lina,Gravallese Ellen M.,Taurog Joel D.,van de Sande Marleen,van Duivenvoorde Leonie M.,Baeten Dominique L.

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference65 articles.

1. Spondyloarthritis;Dougados;Lancet.,2011

2. Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis;Baeten;N Engl J Med.,2015

3. Long-term effects of interleukin-17A inhibition with secukinumab in active ankylosing spondylitis: 3-year efficacy and safety results from an extension of the Phase 3 MEASURE 1 trial;Baraliakos;Clin Exp Rheumatol.,2018

4. Long-term efficacy and safety of secukinumab 150 mg in ankylosing spondyloarthritis: 5-year results from the phase III MEASURE 1 extension study;Gorman;RMD Open.,2019

5. Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study;Braun;Ann Rheum Dis.,2017

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The management of axial spondyloarthritis with cutting-edge therapies: advancements and innovations;Expert Opinion on Biological Therapy;2024-08-02

2. Norisoboldine, a Natural Alkaloid from Lindera aggregata (Sims) Kosterm, Promotes Osteogenic Differentiation via S6K1 Signaling Pathway and Prevents Bone Loss in OVX Mice;Molecular Nutrition & Food Research;2024-05-30

3. JAK-STAT Signaling and Beyond in the Pathogenesis of Spondyloarthritis and Their Clinical Significance;Current Rheumatology Reports;2024-03-16

4. Fibroblast Insights into the Pathogenesis of Ankylosing Spondylitis;Journal of Inflammation Research;2023-12

5. Beyond the horizon: Innovations and future directions in axial-spondyloarthritis;Archives of Rheumatology;2023-11-22